Veterinary Medicines

Intubeaze 20 mg/ml laryngopharyngeal spray, solution for cats

Authorised
  • Lidocaine hydrochloride monohydrate
Download as PDF

Product identification

Medicine name:
Intubeaze 20 mg/ml laryngopharyngeal spray, solution for cats
LIDCOSAL 16,2 MG/ML SOLUTION POUR PULVERISATION LARYNGOPHARYNGEE POUR CHATS
Active substance:
  • Lidocaine hydrochloride monohydrate
Target species:
  • Cat
Route of administration:
  • Laryngopharyngeal use

Product details

Active substance and strength:
  • Lidocaine hydrochloride monohydrate
    20.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Laryngopharyngeal spray, solution
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QR02AD02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • France
Package description:
  • A clear, colourless Type I glass vial with a polypropylene and polyethylene spray pump and actuator containing 10 ml. Vial packaged in a cardboard box.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Dechra Regulatory B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Genera d.d.
Responsible authority:
  • French Agency For Food, Environmental And Occupational Health & Safety
Authorisation number:
  • FR/V/4233977 1/2018
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0554/001
Concerned member states:
  • Austria
  • Belgium
  • Denmark
  • Finland
  • France
  • Germany
  • Italy
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 3/05/2024
Download
French (PDF)
Published on: 10/02/2023
Download